These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Classification and prognosis of chronic hepatitis]. Erlinger S; Degott C Gastroenterol Clin Biol; 1979; 3(8-9):673-82. PubMed ID: 389728 [No Abstract] [Full Text] [Related]
12. [Pathophysiologic, pathomorphologic and clinical principles of a rational liver therapy]. Franken FH Hippokrates; 1971 Mar; 42(1):25-39. PubMed ID: 5550582 [No Abstract] [Full Text] [Related]
13. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents]. Bannaski H Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553 [No Abstract] [Full Text] [Related]
14. The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease. Dudley FJ; Scheuer PJ; Sherlock S Gut; 1972 Oct; 13(10):852. PubMed ID: 5087111 [No Abstract] [Full Text] [Related]
15. [Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis]. Rudyk BI Vrach Delo; 1973 Sep; 9():89-93. PubMed ID: 4768488 [No Abstract] [Full Text] [Related]
19. [Interpretation possibilities of the presence of Australia antigen (Au. an.) in patients with chronic hepatitis and hepatic cirrhosis]. Turcu E; Efanov A; Macarie C Med Interna (Bucur); 1973 Sep; 25(9):1127-34. PubMed ID: 4209305 [No Abstract] [Full Text] [Related]